Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by ICORG- All Ireland Cooperative Oncology Research Group
Sponsor:
Information provided by (Responsible Party):
ICORG- All Ireland Cooperative Oncology Research Group
ClinicalTrials.gov Identifier:
NCT02051010
First received: January 24, 2014
Last updated: August 11, 2014
Last verified: August 2014

January 24, 2014
August 11, 2014
May 2013
July 2015   (final data collection date for primary outcome measure)
Needs of MBC patients in Ireland [ Time Frame: Following analysis of the questionnaires completed by the patients, estimated 24 months ] [ Designated as safety issue: No ]
The needs of MBC patients to be identified and categorised with particular focus on; quality of life, symptom burden and access to and value of available support
Same as current
Complete list of historical versions of study NCT02051010 on ClinicalTrials.gov Archive Site
Future service developments [ Time Frame: Following analysis of the questionnaires completed by patients, estimated 24 months ] [ Designated as safety issue: No ]
Evaluation of future service developments that will provide support to these patients
Same as current
Not Provided
Not Provided
 
ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?
ABC Survey: Are we Meeting the Needs of Patients With Advanced Breast Cancer (ABC) in Ireland? A Nationwide Survey

The study will follow a descriptive design involving a survey. Data collection will involve paper based questionnaires. The questionnaires have been developed in conjunction with breast cancer support groups associated with the Irish Cancer Society and patients.

The purpose of the study is to identify and categorise the need of Metastatic Breast Cancer (MBC) patients in Ireland with particular focus on; quality of life, symptom burden and access to and value of support available.

The study also aims to evaluate future service developments that will provide support to these patients.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

All patients must have metastatic breast cancer

Metastatic Breast Cancer
Not Provided
Metastatic Breast Cancer
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
500
Not Provided
July 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Signed written informed consent
  • Clinical diagnosis of MBC
  • Female aged 18 years or older
  • Able to complete the questionnaires independently

Exclusion Criteria:

  • Any patient who does not meet the above mentioned inclusion criteria.
Female
18 Years and older
No
Ireland
 
NCT02051010
ICORG 13-01
No
ICORG- All Ireland Cooperative Oncology Research Group
ICORG- All Ireland Cooperative Oncology Research Group
Not Provided
Not Provided
ICORG- All Ireland Cooperative Oncology Research Group
August 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP